A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 4, 2002, Pages 699-705

  Gordon, F H ^a   Hamilton, M I ^a   Donoghue, S ^b   Greenlees, C ^b   Palmer, T ^b   Rowley Jones, D ^b   Dhillon, A P ^a   Amlot, P L ^a   Pounder, R E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Elan Pharma Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; AZATHIOPRINE; C REACTIVE PROTEIN; MESALAZINE; MONOCLONAL ANTIBODY; NATALIZUMAB; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEADACHE; HUMAN; LETHARGY; MALE; PERIPHERAL LYMPHOCYTE; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SCORING SYSTEM; SIGMOIDOSCOPY; SORE THROAT; TREATMENT OUTCOME; ULCERATIVE COLITIS; VOMITING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; COLITIS, ULCERATIVE; FEMALE; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; INTEGRIN ALPHA4; MALE; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; SIGMOIDOSCOPY; TREATMENT OUTCOME;

EID: 0036110371     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01205.x     Document Type: Article

References (23)

1. Traffic signals for lymphocyte re-circulation and leukocyte emigration: The multi-step paradigm
2. Physiological and molecular mechanisms of lymphocyte homing
3. Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue
4. Expression of β1-integrins on CD4-positive lamina propria lymphocytes (LPL) of patients with Crohn's disease (CD) and ulcerative colitis (UC)
5. Altered expression of α4β7, a gut homing integrin, by circulating and mucosal T-cells in colonic mucosal inflammation
6. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody
7. Attenuation of colitis in the cotton-top tamarin by anti-α4 integrin monoclonal antibody
8. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to gut-homing integrin α4β7
9. An ascending dose trial of a humanized α4β7 antibody in ulcerative colitis
10. Humanization of a mouse antibody against human alpha-4 integrin: A potential therapeutic for the treatment of multiple sclerosis
11. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin
12. The effect of anti-α4 integrin antibody on brain lesion activity in multiple sclerosis
13. Randomized double-blind placebo-controlled trial of recombinant humanised antibody to α4 integrin (Antegren™) in active Crohn's disease
14. A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha-4 integrin, in active Crohn's disease
15. National Cooperative Crohn's Disease study: Adverse reactions to study drugs
16. A comparison of oral prednisolone given as a single or multiple daily doses for active proctocolitis
17. Differential diagnosis, ulcerative colitis. Crohn's disease and other disorders including diverticular disease
18. Activation of antigen expression on human T cells. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue
19. Variation between observers in describing mucosal appearance in proctocolitis
20. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology and fecal Indium 111-granulocyte excretion
21. A new measure of health status for clinical trials in inflammatory bowel disease
22. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease